Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 1066-1081

  Gibril, Fathia ^a   Chen, Yuan Jia ^a   Schrump, David S ^b   Vortmeyer, Alexander ^c   Zhuang, Zhengping ^c   Lubensky, Irina A ^c   Reynolds, James C ^d   Louie, Adeline ^d   Entsuah, Laurence K ^a   Huang, Kane ^a   Asgharian, Behnam ^a   Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; INTERFERON; OCTREOTIDE; PENTETREOTIDE;

ADULT; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOID; CAUSE OF DEATH; CHROMOSOME 11Q; CHROMOSOME LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCINTIGRAPHY; THORAX RADIOGRAPHY; THYMUS CARCINOID; TUMOR BIOPSY;

ADULT; CARCINOID TUMOR; CHROMOSOMES, HUMAN, PAIR 11; HUMANS; LOSS OF HETEROZYGOSITY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; RECEPTORS, SOMATOSTATIN; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; ZOLLINGER-ELLISON SYNDROME;

EID: 0037339005     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021314     Document Type: Article

References (98)

1. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA 1998 Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129:484-494
2. Metz DC, Jensen RT, Bale AE, Skarulis MC, Eastman RC, Nieman L, Norton JA, Friedman E, Larrson C, Amorosi A, Brandi ML, Marx SJ 1994 Multiple endocrine neoplasia type 1: clinical features and management. In: Bilezekian JP, Levine MA, Marcus R, eds. The parathyroids. New York: Raven Press; 591-646
3. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepherd JJ 1993 Cause of death in multiple endocrine neoplasia type 1. Arch Surg 128:683-690
4. Rosai J, Higa E, Davie J 1972 Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis. A previously unrecognized association. Cancer 29:1075-1083
5. Teh BT, Zedenius J, Kytola S, Skogseid B, Trotter J, Choplin H, Twigg S, Famebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P 1998 Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 228:99-105
6. Zeiger MA, Swartz SE, MacGillivray DC, Linnoila I, Shakir M 1992 Thymic carcinoid in association with MEN syndromes. Am Surg 58:430-434
7. Jensen RT 1998 Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 243:477-488
8. Shepherd JJ 1991 The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized. Arch Surg 126:935-952
9. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falehetti A, Gheri RG, Libroia A, Lips CJM, Lombardi G, Mannelli M, Pacini F, Ponder BAJ, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells Jr SA, Marx SJ 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671
10. Teh BT, McArdle J, Chan SP, Menon J, Hartley L, Pullan P, Ho J, Khir A, Wilkinson S, Larsson C, Cameron D, Shepherd J 1997 Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine 76:21-29
11. Benya RV, Metz DC, Venzon DJ, Fishbeyn VA, Strader DB, Orbuch M, Jensen RT 1994 Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am J Med 97:436-444
12. Gibril F, Venzon DJ, Ojeaburu JV, Bashir S, Jensen RT 2001 Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab 86:5282-5293
13. Roy P, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT 2000 Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine (Baltimore) 79:379-411
14. Fishbeyn VA, Norton JA, Benya RV, Pisegna JR, Venzon DJ, Metz DC, Jensen RT 1993 Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach. Ann Intern Med 119:199-206
15. Roy P, Venzon DJ, Feigenbaum KM, Koviack PD, Bashir S, Ojeaburu JV, Gibril F, Jensen RT 2001 Gastric secretion in Zollinger-Ellison syndrome: correlation with clinical expression, tumor extent and role in diagnosis. A prospective NIH study of 235 patients and review of the literature in 984 cases. Medicine (Baltimore) 80:189-222
16. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, Vinayek R, Gardner JD, Jensen RT 1989 Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: a prospective study. Ann Intern Med 111:713-722
17. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT 1996 Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 125:26-34
18. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT 2001 Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 234:495-506
19. Gibril F, Doppman JL, Reynolds JC, Chen CC, Sutliff VE, Yu F, Serrano J, Venzon DJ, Jensen RT 1998 Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and MRI in their detection, their frequency, location and effect of their detection on management. J Clin Oncol 16:1040-1053
20. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini P, Roy PK, Gibril F, Jensen RT 1999 Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341:635-644
21. Shojamanesh H, Gibril F, Louie A, Ojeaburu JV, Bashir S, Abou-Saif A, Jensen RT 2002 Prospective study of the anti-tumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinomas. Cancer 94:331-343
22. von Schrenck T, Howard JM, Doppman JL, Norton JA, Maton PN, Smith FP, Vinayek R, Frucht H, Wank SA, Gardner JD, Jensen RT 1988 Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 94:1326-1334
23. Pisegna JR, Slimak GG, Doppman JL, Strader DB, Metz DC, Fishbeyn VA, Benya RV, Orbuch M, Fraker DL, Norton JA, Maton PN, Jensen RT 1993 An evaluation of human recombinant α interferon in patients with metastatic gastrinoma. Gastroenterology 105:1179-1183
24. Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD, Frohman LA 2000 Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab 85:707-714
25. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ 1997 Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16:375-378
26. Rosai J, Higa E 1972 Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer 29:1061-1074
27. Jose CC, Varghese CV, Singh AD 1988 Thymic carcinoid in a case of Zollinger-Ellison syndrome. A case report. Australas Radiol 32:408-409
28. Cupisti K, Dotzenrath C, Simon D, Goretzki PE, Roher HD 1997 Surgical therapy of neuroendocrine tumors of the thymus. Chirurg 68:136-140
29. Sugiura H, Morikawa T, Itoh K, Ono K, Okushiba S, Kondo S, Kato H 2001 Thymic carcinoid in a patient with multiple endocrine neoplasia type 1: report of a case. Surg Today 31:428-432
30. Eberle F, Martini GA, Scheuer A, Rohr G, Sohl R, Bischof W, Wahl R 1982 Thymus carcinoid tumor and multiple endocrine neoplasia type I (MEN1). Internist (Berl) 23:718-724
31. Frilling A, Becker H, Roeher HD 1992 Unusual features of multiple endocrine neoplasia. Henry Ford Hosp Med J 40:253-255
32. Manes JL, Taylor HB 1973 Thymic carcinoid in familial multiple endocrine adenomatosis. Arch Pathol 95:252-255
33. Mari C, Leon J, Farrerons J, Matis-Guiu X, Tembl A, Martin JC, Flotats A, Berna L 1999 Thymic carcinoid and parathyroid hyperplasia detection with 99mTc-MIBI men type 1. J Endocrinol Invest 22:803-807
34. Hirai S, Hamanaka Y, Mitsui N, Kumagai H, Kobayashi T 2001 Thymic carcinoids in multiple endocrine neoplasia-type 1. Jpn J Thorac Cardiovasc Surg 49:525-527
35. Perez-Monte JE, Brown ML, Clarke MR, Watson CG, Carty SE 1997 Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium-99m-MIBI in MEN type I. J Nucl Med 38:1767-1769
36. Isenberg DA, Linch D, Brenton DP, Smith JF 1981 A case of carcinoid tumour of the thymus in association with hyperparathyroidism. Clin Oncol 7:61-67
37. Satta J, Ahonen A, Parkkila S, Leinonen L, Apaja-Sarkkinen M, Lepojarvi M, Juvonen T 1999 Multiple endocrine neoplastic-associated thymic carcinoid tumor in close relatives: octreotide scan as a new diagnostic and follow-up modality. Scand Cardiovasc J 33:49-53
38. Paja Fano M, Goni Goicoechea F, Yoldi Arrieta A, Ramon Elorza Olabegoya J 2001 Type 1 multiple endocrine neoplasia associated to thymic carcinoid. Clinical and genetic study of one case. Med Clin (Barc) 116:39
39. Cadigan DG, Hollett PD, Collingwood PW, Ur E 1996 Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue. Clin Nucl Med 21:487-488
40. Floros D, Dosios T, Tsourdis A, Yiatromanolakis N 1982 Carcinoid tumor of the thymus with multiple endocrine adenomatosis. Pathol Res Pract 175:404-409
41. Birnberg FA, Webb WR, Selch MT, Gamsu G, Goodman PC 1982 Thymic carcinoid tumors with hyperparathyroidism. AJR Am J Roentgenol 139:1001-1004
42. Farid NR, Buchler S, Russell NA, Maroun FB, Allerdice P, Smyth HS 1980 Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors. Am J Med 69:874-880
43. Palacios N, Cordido F, Rapado A, Castrillo JM, Alix A, Carrasco MA 1986 Association of thoracic carcinoid tumor and hyperparathyroidism. Presentation of 2 cases. Rev Clin Esp 178:70-73
44. Traylor FA, McGee HH, Stephenson DJ 1967 Case 5: carcinoid of ectopic parathyroid. Penrose Cancer Seminar IV:50-53
45. Vener JD, Zuckerbraun L, Goodman D 1982 Carcinoid tumor of the thymus associated with a parathyroid adenoma. Arch Otolaryngol 108:324-326
46. Duh QY, Hybarger CP, Geist R, Gamsu G, Goodman PC, Gooding GA, Clark OH 1987 Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154:142-148
47. Lokich JJ, Li F 1978 Carcinoid of the thymus with hereditary hyperparathyroidism. Ann Intern Med 89:364-365
48. Dusenbery D 1996 Spindle-cell thymic carcinoid occurring in multiple endocrine neoplasia I: fine-needle aspiration findings in a case. Diagn Cytopathol 15:439-441
49. Carty SE, Helm AK, Amico JA, Clarke MR, Foley TP, Watson CG, Mulvihill JJ 1998 The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124:1106-1114
50. deMontpreville VT, Macchiarini P, Dulmet E 1996 Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 111:134-141
51. Giraud S, Choplin H, Teh BT, Lespinasse J, Jouvet A, Labat-Moleur F, Lenoir G, Hamon B, Hamon P, Calender A 1997 A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. J Clin Endocrinol Metab 82:3487-3492
52. Hessman O, Skogseid B, Westin G, Akerstrom G 2001 Multiple allelic deletions and intratumoral genetic heterogeneity in MEN1 pancreatic tumors. J Clin Endocrinol Metab 86:1355-1361
53. Wick MR, Scott RE, Li CY, Carney JA 1980 Carcinoid tumor of the thymus: a clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc 55:246-254
54. Miyauchi A, Sato M, Matsubara S, Ohye H, Kihara M, Matsusaka K, Nishitani A, Takahara J 1998 A family of MEN1 with a novel germline missense mutation and benign polymorphisms. Endocr J 45:753-759
55. Zahner J, Borchard F, Schmitz U, Schneider W 1994 Thymus carcinoid in multiple endocrine neoplasms. Dtsch Med Wochenschr 119:135-140
56. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A, Thakker RV 1996 Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89:653-669
57. Blayney DW 1990 Thymic carcinoid and multiple endocrine neoplasia. West J Med 152:426
58. Sakurai A, Katai M, Itakura Y, Nakajima K, Baba K, Hashizume K 1996 Genetic screening in hereditary multiple endocrine neoplasia type 1: absence of a founder effect among Japanese families. Jpn J Cancer Res 87:985-994
59. Murat A, Heymann MF, Bernat S, Dupas B, Delajartre AY, Calender A, Despins P, Michaud JL, Giraud S, LeBodic MF, Charbonnel B 1997 Thymic and bronchial neuroendocrine tumors in multiple endocrine neoplasia type 1. GENEM1. Presse Med 26:1616-1621
60. Kanno R, Yanai K, Ohishi A, Noue H, Motoki R 1997 Recurrent thymic carcinoid tumor with multiple endocrine neoplasia syndrome: a case report. Nippon Kyobu Geka Gakkai Zasshi 45:213-219
61. Kondo R, Yamanda T, Makiuchi A, Numanami H, Takasuna K, Machida E, Miyazawa M, Yoshida K, Aoki T, Haniuda M, Amano J 1999 A case of thymic carcinoid with multiple endocrine neoplasm (MEN)-type I. Kyobu Geka 52:875-878
62. Dreijerink KM, Roijers JF, Jansen-Schillhorn van Veen JM, Neijt JP, van Vroonhoven TJ, Lips CJ 2000 Diverse expression of multiple endocrine neoplasia type 1. Ned Tijdschr Geneeskd 144:2437-2442
63. Hill DM, Anderson J, Marks V 1967 Pluriglandular syndrome: multiple endocrine neoplasia. Proc Roy Soc Med 60:650-651
64. Venkatesh S, Samaan NA 1990 Carcinoid tumors of the thymus. West J Med 152:72-74
65. Auguste LJ, Masood S, Westerband A, Belluco C, Valderamma E, Attie J 1992 Oncogene expression in follicular neoplasms of the thyroid. Am J Surg 164:592-593
66. Axelson J, Kobari M, Furukawa T, Matsuno S 1999 Thymic carcinoid in the pancreas: metastatic disease or new primary tumours. Eur J Surg 165:270-273
67. Dotzenrath C, Goretzki PE, Cupisti K, Yang Q, Simon D, Roher HD 2001 Malignant endocrine tumors in patients with MEN1 disease. Surgery 129:91-95
68. Cerezo FJM, Garreta J, Gonzalez T, Gallel P, Miralbes M 1996 Thymus carcinoid associated with type 1 multiple endocrine neoplasia. Med Clin (Barc) 106:21-23
69. Burgess JR, Giles N, Shepherd JJ 2001 Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 55:689-693
70. Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund M, Nies C 2000 Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128:958-966
71. Ferolla P, Falchetti A, Morelli A, Avenia N, Daddi G, Ribacchi R, Brandi ML, Angeletti G, Thymic neuroendocrine carcinoma (carcinoid) in MEN1 syndrome: characterization of the three Italian cases. Eighth International Workshop on Multiple Endocrine Neoplasia, Grand Rapids, MI, 2002, Abstract 10
72. Lim L-C, Teh B-T, Rajasoorya RC, Familial MEN1 - revisiting traditional dogma - unusual presentations in the first Singapore family with a novel genetic mutation. Eighth International Workshop on Multiple Endocrine Neoplasia, Grand Rapids, MI, 2002 (Abstract 20)
73. Grimfjard P, Speel EJM, Stalberg P, Skogseid B, Clinics and genetics in Men 1 related advanced thymic carcinoids: a triple case report including genome wide screening for genetic alterations. Eighth International Workshop on Multiple Endocrine Neoplasia, Grand Rapids, MI, 2002 (Abstract 15)
74. Green JS, Addetia K, Joyce C, Kaiser S, Galway AB, Carcinoid tumours in MEN-1 (Burin). Eighth International Workshop on Multiple Endocrine Neoplasia, Grand Rapids, MI, 2002 (Abstract 14)
75. Goudet P, Cougard P, Calender A, du Boullay-Choplin H, Murat A, Kraimps L-L, Mignon M, Proye C, Faivre J, Clinical, surgical and genetic studies of 12 cases of thymic neuro endocrine tumors (th-NET) among a cohort of 574 multiple endocrine neoplasia type 1 (MEN1) cases. Eighth International Workshop on Multiple Endocrine Neoplasia, Grand Rapids, MI, 2002 (Abstract 13)
76. Boix E, Pico A, Pinedo R, Aranda I, Kovacs K 2002 Ectopic growth hormone-releasing hormone secretion by thymic carcinoid tumour. Clin Endocrinol (Oxf) 57:131-134
77. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, Gibril F, Metz DC, Fraker DL, Norton JA, Jensen RT 1995 Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108:1637-1649
78. Soga J, Yakuwa Y, Osaka M 1999 Evaluation of 342 cases of mediastial/thymic carcmoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 5:285-292
79. Jansson JO, Svensson J, Bengtsson BA, Frohman LA, Ahlman H, Wangberg B, Nilsson O, Nilsson M 1998 Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6. Clin Endocrinol (Oxf) 48:243-250
80. Teh BT 1998 Thymic carcinoids in multiple endocrine neoplasia type 1. J Intern Med 243:501-504
81. Ferone D, van Hagen PM, Colao A, Annurtziato L, Lamberts SWJ, Hofland LJ 1999 Somatostatin receptors in the thymus. Ann Med 31:28-33
82. Ferone D, Vanhagen PM, Pivonello R, Colao A, Lamberts SWJ, Hofland LJ 2000 Physiological and pathophysiological role of somatostatin receptors in the human thymus. Eur J Endocrinol 143:S27-S34
83. Jensen RT 1997 Peptide therapy. Recent advances in the use of somatostatin and other peptide receptor agonists and antagonists. In: Lewis JH, Dubois A, eds. Current clinical topics in gastrointestinal pharmacology. Malden, MA: Blackwell Science, Inc.; 144-223
84. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716-731
85. Kwekkeboom D, Krenning EP, deJong M 2000 Peptide receptor imagIng and therapy. J Nucl Med 41:1704-1713
86. Silva F, Vazquez-Selles J, Aguilo F, Vazquez G, Flores C 1999 Recurrent ectopic adrenocorticotropic hormone producing thymic carcinoid detected with octreotide imaging. Clin Nucl Med 24:109-110
87. Matejka G, Toubeau M, Bernard A, Belleville Y, Vaillant G, Brun JM 1996 Tumeur carcinoide thymique responable d'un syndrome de cushsing paraneoplasique. Presse Med 25:1201-1202
88. Lastoria S, Vergara E, Palmieri G, Acampa W, Varrella P, Caraco C, Bianco RA, Muto P, Salvatore M 1998 In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phel-octreotide scintigraphy. J Nucl Med 39:634-639
89. Lebtahi R, Cadiot G, Delahaye N, Genin R, Daou D, Peker MC, Chosidow D, Faraggi M, Mignon M, LeGuludec D 1999 Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 40:1602-1608
90. Bordi C, Falchetti A, Azzoni C, D'Adda T, Canavese G, Guariglia A, Santini D, Tomassetti P, Brandi ML 1997 Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol 21:1075-1082
91. Debelenko LV, Zhuang ZP, Emmert-Buck MR, Chandrasekharappa S, Manickam P, Guru SC, Marx SJ, Skarulis M, Spiegel AM, Collins FS, Jensen RT, Liotta LA, Lubensky IA 1997 Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type-I-associated sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 57:2238-2243
92. Debelenko LV, Emmert-Buck MR, Zhuang Z, Epshteyn E, Moskaluk CA, Jensen RT, Liotta LA, Lubensky IA 1997 The multiple endocrine neoplasia type 1 gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 113:773-782
93. Economopoulos GC, Lewis Jr JW, Lee MW, Silverman NA 1990 Carcinold tumors of the thymus. Ann Thorac Surg 50:58-61
94. Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, Murase T, Eimoto T 1999 Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg 67:208-211
95. Schupak KD, Wallner KE 1991 The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors. Int J Radiat Oncol Biol Phys 20:489-495
96. Chakravarthy A, Abrams RA 1995 Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer 75:1386-1390
97. Chan KY, Tang NL, Yim AP, Chung SS, Lee TW, Ho JK 1996 A case report of a large thymic carcinoid. Ann Acad Med Singapore 25:584-586
98. Abrams RA, King D, Wilson JF 1987 Objective response of malignant carcinoid to radiation therapy. Int J Radiat Oncol Biol Phys 13:869-873